Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abeona Therapeutics (ABEO) Total Current Liabilities (2016 - 2025)

Abeona Therapeutics has reported Total Current Liabilities over the past 15 years, most recently at $29.6 million for Q4 2025.

  • Quarterly results put Total Current Liabilities at $29.6 million for Q4 2025, up 78.27% from a year ago — trailing twelve months through Dec 2025 was $29.6 million (up 78.27% YoY), and the annual figure for FY2025 was $29.6 million, up 78.27%.
  • Total Current Liabilities for Q4 2025 was $29.6 million at Abeona Therapeutics, up from $22.2 million in the prior quarter.
  • Over the last five years, Total Current Liabilities for ABEO hit a ceiling of $41.9 million in Q2 2021 and a floor of $7.4 million in Q1 2023.
  • Median Total Current Liabilities over the past 5 years was $16.6 million (2021), compared with a mean of $18.9 million.
  • Biggest five-year swings in Total Current Liabilities: plummeted 69.79% in 2022 and later soared 119.0% in 2024.
  • Abeona Therapeutics' Total Current Liabilities stood at $16.6 million in 2021, then crashed by 53.2% to $7.8 million in 2022, then surged by 72.54% to $13.4 million in 2023, then rose by 23.58% to $16.6 million in 2024, then soared by 78.27% to $29.6 million in 2025.
  • The last three reported values for Total Current Liabilities were $29.6 million (Q4 2025), $22.2 million (Q3 2025), and $34.5 million (Q2 2025) per Business Quant data.